| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |